X0306 4 2013-09-13 0 0001070698 Raptor Pharmaceutical Corp RPTP 0001349376 Walbert Timothy P C/O RAPTOR PHARMACEUTICAL CORP. 5 HAMILTON LANDING, SUITE 160 NOVATO CA 94949 1 0 0 0 Common Stock 2013-09-13 4 M 0 5520 3.33 A 5520 D Common Stock 2013-09-13 4 S 0 5520 14.0702 D 0 D Stock options (right to buy) 3.33 2013-09-13 4 M 0 5520 0 D 2011-10-11 2021-04-10 Common Stock 5520 69480 D Stock options (right to buy) 5.13 2011-12-22 2021-09-21 Common Stock 15000 15000 D Stock options (right to buy) 5.13 2012-03-22 2021-09-21 Common Stock 90000 90000 D Stock options (right to buy) 5.49 2012-12-25 2022-09-24 Common Stock 50000 50000 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 27, 2013. Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter. Fully vested and exercisable. Stock options vest 25% quarterly. The shares listed as owned in column 9 represent the total shares for each respective option. Previous reports reflected aggregate amounts of option shares in column 9. The holding lines included on this Form 4 are included solely to correct the breakdown of shares among various stock options and are not meant to reflect any change in beneficial ownership of option shares other than those reported as a transaction on this Form 4. /s/ Kim R. Tsuchimoto, Raptor Pharmaceutical Corp., Attorney-in-fact 2013-09-17